Views & Analysis | Perspectives on pharma industry issues

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Digital

AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Views & Analysis

Who will pay the price for inaction on superbugs?

While the UK government has been applauded for its efforts in raising awareness about antimicrobial resistance, its efforts to convince pharma to invest in new antibiotics have so far been

Views & Analysis

Understanding muscular dystrophy

Chris Anselmo, who has a rare form of muscular dystrophy, hopes to educate pharma on the patient journey and help new patients cope with a life-changing diagnosis.

R&D

Chris Molloy from the Medicines Discovery Catapult on the pharmaphorum podcast

The state of UK drug discovery: the pharmaphorum podcast

The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the

Sales & Marketing

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Sales & Marketing

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Digital

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.